Delta-opioid agonist SNC80 can attenuate the development of dynorphin A-induced tactile allodynia in rats.
Kawaraguchi
Yoshitaka
Y
Department of Anesthesiology, Nara Medical University, Kashihara, Nara, Japan. drjkawa@naramed-u.ac.jp
Kawaguchi
Masahiko
M
Takahashi
Masahiro
M
Horiuchi
Toshinori
T
Sakamoto
Takanori
T
Furuya
Hitoshi
H
D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D002404:Catheterization; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004399:Dynorphins; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D007278:Injections, Spinal; D008297:Male; D009619:Nociceptors / Q000187:drug effects; D010146:Pain / Q000139:chemically induced* / Q000517:prevention & control*; D010812:Physical Stimulation; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000819:agonists*
D001549:Benzamides; D018691:Excitatory Amino Acid Antagonists; D010879:Piperazines; D017465:Receptors, Opioid, delta; C088464:4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide; D016291:Dizocilpine Maleate; D004399:Dynorphins